Medical nutrition therapy (MNT) for patients with diabetes or obesity-related complications
If you want individualized guidance or want to learn how Mochi supports patients through plateaus, you can check your eligibility here
There was no notable effect of treatment on body weight, BMI, or blood pressure ( More recently, the T2NOW trial compared dapagliflozin and saxagliptin (a dipeptidyl peptidase-4 inhibitor (DPP - 4i)) separately versus a single placebo group
[2] Your GP may: Refer you to psychological services if anxiety symptoms are significant, including NHS Talking Therapies for anxiety and depression Consider whether anxiety treatment should be optimised before or alongside GLP-1 therapy, following NICE guidance for anxiety disorders Coordinate care with diabetes specialists, dietitians, and mental health professionals Review the risk-benefit balance of continuing GLP-1 treatment if mental health concerns arise Screen for and manage eating disorders according to NICE guidance before initiating or continuing weight-loss treatments Remember that GLP-1 medications are not a treatment for anxiety, and any mental health benefits are likely secondary to metabolic improvements
Subclinical B12 deficiency, however, is far more prevalent, affecting up to 26% of the general population